STACEY FLINT: Open Payments
NPI 1427593722 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 15 payments from 8 companies in 2025. Trend: 2023 $44 · 2024 $436 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Actelion Pharmaceuticals US, Inc. | 1 | $79 |
| PFIZER INC. | 4 | $76 |
| CVRx, Inc. | 2 | $67 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Boston Scientific Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: LEQVIO, UPTRAVI, Barostim Neo System, VYNDAQEL, ELIQUIS, FUROSCIX, CAMZYOS, WATCHMAN FLX.
Industry payments across UT — which companies pay providers there.
